Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Subset specification of central serotonergic neuronsPlacental transfer of antidepressant medications: implications for postnatal adaptation syndromePrenatal antidepressant exposure: clinical and preclinical findings.Paradoxical anxiogenic response of juvenile mice to fluoxetineExcess of serotonin affects neocortical pyramidal neuron migrationRisk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine.Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.Serotonin, genetic variability, behaviour, and psychiatric disorders--a reviewFluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescenceNeurobehavioral manifestations of developmental impairment of the brain.Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptakeThe effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetusMolecular cloning and in silico analysis of the duck (Anas platyrhynchos) MEF2A gene cDNA and its expression profile in muscle tissues during fetal development.Neonatal SSRI Exposure Programs a Hypermetabolic State in Adult Mice.Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Serotonin has early, cilia-independent roles in Xenopus left-right patterning.The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Sertraline exposure leads to small left heart syndrome in adult mice.Cardiac dysfunction and prenatal exposure to venlafaxine.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringGenetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes.Third Trimester Equivalent Alcohol Exposure Reduces Modulation of Glutamatergic Synaptic Transmission by 5-HT1A Receptors in the Rat Hippocampal CA3 Region.More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders.Fetal behavioral teratology.Monoamine oxidases in development.Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring.Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood.Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.Cardiac Outcomes After Perinatal Sertraline Exposure in Mice.Neonatal fluoxetine exposure alters motor performances of adolescent rats.Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring.
P2860
Q26741187-D657B633-A718-4F4B-AE3F-7A10EB4544CFQ26827511-82AC4803-75FD-4A82-8C48-244C8D5285E1Q26999391-00D75052-12A7-448F-BAF6-FA5C404CC5A1Q30415540-9A4553D6-94CE-4EC7-9E25-3F9ABF173E8DQ30491364-9BD629C6-02A8-4EEE-A059-1880675C43FDQ30511877-0FBFA3EE-7EB2-499D-95E6-CB10A169C57EQ30818739-D49D637F-80D0-453E-BB28-104A782C12D2Q33483653-B1166E87-A22A-4ED4-AF05-E8A8AA188041Q33784153-6DE15DB8-DB2F-46F5-A55C-9158421F1D4FQ34017808-4A2562B7-D3ED-4585-8947-A3D5BE65DFB0Q34320110-94D4AD19-CC55-4465-AAD6-7DE59317030CQ34483257-12B01F5E-6E1F-4516-BBBC-FC37A8A256E0Q34714284-F8D69DDB-55A1-4C95-9131-DD9ADFDBE7BCQ34832393-CB4A7541-9D66-4F39-8BB2-EB1B204C46D0Q35000963-6400897A-CC03-4D53-B56B-9FE08E7CA1F3Q35090255-050BBFC0-C7EB-4886-9D8E-0606207630FBQ35171321-C4423EE3-AFF4-4957-8392-88610C787C7CQ35855413-A1BD6CBB-2458-45FB-82F4-BD015891DCDDQ35909234-5D64E21A-3FDC-4D00-977C-9AF767153D0EQ36213523-B34C70AD-8A01-4485-B5DD-65C60536E3FBQ36486059-F6E84973-9949-43B1-8153-57A18C6111EAQ36706789-F52AB388-91A0-4632-8585-142C439913A1Q36712871-FCC46FB6-E738-4AE5-A39A-E4B681BE3613Q36797574-EB21F15D-BBA1-4A09-AC06-106B05B9CDE9Q36860205-C80985B3-3864-411E-BBA3-8285B33F9BACQ36921232-91A3E5FF-3A6F-4CDA-AF55-E345156DE783Q36939119-E2DD133C-33A9-45A9-981E-0AB166D5BC05Q36978761-CBB60B8D-204E-4DAC-81AC-C39EBF49937CQ37334235-98205321-4847-4758-86A0-2E62C31F69B3Q37337705-199A643F-5589-45C0-AEC0-3BCB9C74C83CQ37699993-22F9F9C6-C2F5-4E72-875B-35889603A539Q37793067-FE8D0644-36C2-451B-8641-C1BB959AF6C6Q38025300-51CA7E6A-6EC9-45D3-AD7C-D999212F36D5Q38857229-7B6217A3-72C5-45C2-875C-EFEF78BA4E03Q40274241-120463AF-A7D9-483B-AF77-773F4645AC19Q42609484-C0F4BEC6-881E-4E97-9380-2FEEA1613EF9Q47743073-CDE404CB-49F1-4F5C-8A42-2DFB002A97BDQ47777271-724BBB7E-6189-4C87-A9C7-9C90D033F090Q49114726-5626F785-E89E-4B26-B407-917076B25E15Q50633608-1395ACDC-D8FA-4BE2-909C-EE0B46A8AD38
P2860
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Modulation of serotonin transp ...... elong behavioral abnormalities
@ast
Modulation of serotonin transp ...... elong behavioral abnormalities
@en
Modulation of serotonin transp ...... elong behavioral abnormalities
@nl
type
label
Modulation of serotonin transp ...... elong behavioral abnormalities
@ast
Modulation of serotonin transp ...... elong behavioral abnormalities
@en
Modulation of serotonin transp ...... elong behavioral abnormalities
@nl
prefLabel
Modulation of serotonin transp ...... elong behavioral abnormalities
@ast
Modulation of serotonin transp ...... elong behavioral abnormalities
@en
Modulation of serotonin transp ...... elong behavioral abnormalities
@nl
P2093
P2860
P3181
P1433
P1476
Modulation of serotonin transp ...... elong behavioral abnormalities
@en
P2093
Cees J A van Echteld
Cornelle W Noorlander
Frederique F T Ververs
Gerard H A Visser
Peter G J Nikkels
P2860
P3181
P356
10.1371/JOURNAL.PONE.0002782
P407
P577
2008-01-01T00:00:00Z